Shares of Jubilant Life Sciences surged 10.4 per cent in early trade to its highest since October 28. The company has obtained approval from US FDA for two key drugs.

These approvals will act as medium-term positive for the stock, say traders.

At 10.30 am, the stock was up Rs 10.60 or 7.59 per cent at Rs 150.30 on the BSE.

comment COMMENT NOW